Ixia (XXIA) Misses Q2 EPS by 3c

Ixia (Nasdaq: XXIA) reported Q2 EPS of $0.01, $0.03 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $109.5 million versus the consensus estimate of $109.52 million.

“We are pleased that we are now current in filing all required periodic financial reports with the SEC,” said Errol Ginsberg, Ixia's chairman and chief innovation officer. “We would like to thank the investment community and our shareholders for their patience and understanding as we worked to become current with our financial reporting, and we look forward to engaging with them in the months ahead.

“We would also like to express our gratitude to our employees who have remained focused on executing throughout the leadership transition and operational restructuring. Bethany Mayer will join the Ixia team as our president and CEO effective tomorrow, and we are confident she brings the right vision and leadership skills to build upon Ixia’s strong foundation and unique position in networking,” continued Ginsberg.

For earnings history and earnings-related data on Ixia (XXIA) click here.

You May Also Be Interested In

• Outlook Therapeutics posts Q3 loss, eyes U.S. LYTENAVA launch by end of 2026
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Calamp Corp. (CAMP) Misses Q2 EPS by 33c